# Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer

> **NCT00002504** · PHASE2 · COMPLETED · sponsor: **Hoag Memorial Hospital Presbyterian**

## Conditions studied

- Chronic Myeloproliferative Disorders
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Precancerous/Nonmalignant Condition
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** aldesleukin
- **BIOLOGICAL:** recombinant interferon alfa

## Key facts

- **NCT ID:** NCT00002504
- **Lead sponsor:** Hoag Memorial Hospital Presbyterian
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1992-08
- **Primary completion:** 1998-02
- **Final completion:** 1999-02
- **Target enrollment:** — (—)
- **Last updated:** 2011-05-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002504, "Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00002504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*